https://www.indianpharmapost.com/aarti-drugs-posts-q1fy22-consolidated-pat-at-rs-4881-cr-98012021-07-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/granules-india-q1fy22-consolidated-net-profit-at-rs-12020-cr-98022021-07-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/bharat-immunologicals-and-biologicals-corporation-q1fy22-net-profit-at-rs-192-cr-98032021-07-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/torrent-pharmaceuticals-q1fy22-consolidated-pat-up-at-rs-330-cr-98042021-07-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/dr-reddys-laboratories-ltd-q1fy22-consolidated-pat-at-rs-3804-cr-98072021-07-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/morepen-laboratories-posts-q1fy22-consolidated-pat-of-rs-3047-cr-98082021-07-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/hugely-successful-vaccination-roll-out-made-possible-by-india-uk-partnership-98132021-07-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/morepen-to-start-sputnik-v-vaccine-commercial-production-in-4-6-weeks-98142021-07-28T00:00:00+05:30always0.9